Biotechnology Instrumentation Market 2016 Market Growth, Trends, Demand, Share, Analysis to …

Biotechnology Instrumentation Market Production, Supply, Sales, and Demand Research Report is a systematically conducted exhaustive study of the …

Trade Report: The Exelixis Inc. (EXEL) Director George A. Scangos Sold 204718 Shares

Exelixis (NASDAQ:EXEL) last issued its quarterly earnings results on Thursday, November 3rd. The biotechnology company reported ($0.04) earnings …

Trade Report: The Smith Graham & Co. Investment Advisors LP Buys Shares of 27685 United …

The fund purchased 27,685 shares of the biotechnology company’s stock, valued at approximately $3,269,000. Smith Graham & Co. Investment …

Trade Report: The 5000 Shares of United Therapeutics Corp. (UTHR) Stock are sold by the …

The biotechnology company reported $4.36 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $3.38 by $0.98.

Latest report Global hepatitis B pipeline market review and therapeutic development for H2 2016 …

… Arrowhead Pharmaceuticals Inc, Assembly Biosciences Inc, Beijing Kawin Technology Share-Holding Co Ltd, Beijing Minhai Biotechnology Co Ltd, …

The Puma Biotechnology Inc. (PBYI) Given Average Recommendation of “Buy” by the Brokerages

Puma Biotechnology Inc. (NYSE:PBYI) has earned an average rating of “Buy” from the ten ratings firms that are currently covering the company.

The Conatus Pharmaceuticals Inc. (CNAT) Upgrade by The Zacks Investment Research

The firm presently has a $2.25 target price on the biotechnology company’s stock. Zacks Investment Research’s price objective would indicate a …

US Soy Grower Leaders Attend China’s Top-Level Agricultural Summit

Mr. Wilkins warned Chinese policy advisors that biotech approval delays would not only hurt growers and seed developers, but the environment and …

The Teachers Advisors LLC invests in Biogen Inc. (BIIB) Shares

The fund owned 395,208 shares of the biotechnology company’s stock after buying an additional 75,214 shares during the period. Teachers Advisors …

The Rhumbline Advisers Raises its position in Biogen Inc. (BIIB) as a favorable investment target.

The fund owned 357,364 shares of the biotechnology company’s stock after buying an additional 8,533 shares during the period. Rhumbline Advisers’ …

1 39 40 41 42 43 46